Research.Patient.info
Systemic Sclerosis (SSc) research hub
2 indexed studies · 1 currently recruiting
- recruitingPHASE2
Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)
This study is testing a new medicine, tibulizumab, for an illness called systemic sclerosis (scleroderma). We want to see if it helps improve symptoms over 24 weeks, followed by an additional 28 weeks where everyone gets the study drug.
United States · Argentina · Chile - active not recruitingPHASE3
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
This study, DAISY, is testing a new treatment called Anifrolumab for adults with Systemic Sclerosis (also known as Scleroderma). We want to see if it's safe and effective compared to a dummy treatment, to help improve symptoms and quality of life.
United States · Austria · Belgium